Cancer Immunotherapy at the Crossroads

How Tumors Evade Immunity and What Can Be Done

Nonfiction, Health & Well Being, Medical, Specialties, Oncology
Cover of the book Cancer Immunotherapy at the Crossroads by , Humana Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781592597437
Publisher: Humana Press Publication: November 24, 2003
Imprint: Humana Language: English
Author:
ISBN: 9781592597437
Publisher: Humana Press
Publication: November 24, 2003
Imprint: Humana
Language: English

Leading investigators and clinicians detail the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction. The authors review the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors, focusing on tumor-induced molecular defects in T cells and antigen-presenting cells (dendritic cells and tumors), that may serve as biomarkers for patient prognosis. They discuss the means by which these immune functions may be protected or restored in order to more effectively support the process of tumor rejection in situ. Cutting-edge techniques are outlined with the capacity to monitor the strength and quality of patients' immune responses using immunocytometry, MHC-peptide tetramers combined with apoptosis assay, ELISPOT assay, and detection of MHC-TAA peptide complexes on tumor cells.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Leading investigators and clinicians detail the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction. The authors review the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors, focusing on tumor-induced molecular defects in T cells and antigen-presenting cells (dendritic cells and tumors), that may serve as biomarkers for patient prognosis. They discuss the means by which these immune functions may be protected or restored in order to more effectively support the process of tumor rejection in situ. Cutting-edge techniques are outlined with the capacity to monitor the strength and quality of patients' immune responses using immunocytometry, MHC-peptide tetramers combined with apoptosis assay, ELISPOT assay, and detection of MHC-TAA peptide complexes on tumor cells.

More books from Humana Press

Cover of the book Psychodynamic Psychotherapy Research by
Cover of the book A Clinical Guide to Occupational and Environmental Lung Diseases by
Cover of the book Minimally Invasive Cardiac Surgery by
Cover of the book Oxidative Stress in Aging by
Cover of the book Clinical Handbook of Insomnia by
Cover of the book Diarrhea by
Cover of the book Diseases of the Thyroid by
Cover of the book Principles of Molecular Oncology by
Cover of the book Prostate Cancer by
Cover of the book Telomeres and Telomerase in Cancer by
Cover of the book Pocket Handbook of GI Pharmacotherapeutics by
Cover of the book On the Bridge by
Cover of the book Neoplastic Hematopathology by
Cover of the book Discoveries in the Human Brain by
Cover of the book Fibrocystic Diseases of the Liver by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy